17
2
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T12146 |
N-Desmethyl-Apalutamide
N-Desmethyl Apalutamide,N-去甲基阿帕鲁胺杂质 |
P450; Androgen Receptor | Endocrinology/Hormones; Metabolism |
N-Desmethyl-Apalutamide 是一种 Apalutamide 的活性代谢产物,主要由 CYP2C8 和 CYP3A4 介导形成。它是一种低活性的雄激素受体拮抗剂,其作用力是 Apalutamide 活性的三分之一。它是中等至强的CYP3A4和CYP2B6诱导剂,并具有优异的血浆蛋白结合浓度。 | |||
T37149 |
Carbamazepine 10,11-epoxide
|
Others | Others |
Carbamazepine 10,11-epoxide 是抗惊厥药卡马西平 (carbamazepine) 的活性代谢物。它由卡马西平通过微粒体中的细胞色素 P450 (CYP) 同种型 CYP3A4 和 CYP2C8 形成,微粒体分别由表达 CYP3A4 或 CYP2C8 的 HepG2 细胞制备。它对小鼠电击诱发的癫痫发作具有抗惊厥活性。 | |||
T4567 |
Sulfaphenazole
Plisulfan,Raziosulfa,Depocid,磺胺苯吡唑,Depotsulfonamide |
P450; Antibacterial | Metabolism; Microbiology/Virology |
Sulfaphenazole (Plisulfan) 是一种 CYP2C9的特异性抑制剂,抑制 CYP2C9介导的亚油酸动脉粥样硬化和促炎症效应,增加 AP-1的氧化应激和激活。 | |||
T41291 |
MS-PPOH
|
P450 | Metabolism |
MS-PPOH 是一种有效的选择性细胞色素 P450 (CYP) 环氧化酶抑制剂。MS-PPOH 抑制 CYP2C8 和 CYP2C9,IC50 分别为 15 和 11 µM。 | |||
T1149 |
Fenofibrate
Procetofen,非诺贝特,Lipanthyl,Lipantil |
P450; PPAR; Autophagy | Autophagy; DNA Damage/DNA Repair; Metabolism |
Fenofibrate (Lipanthyl) 是一种选择性PPARα激动剂,EC50为 30 μM。它是一种合成的苯氧基异丁酸衍生物和前药,具有抗高血脂活性。它抑制细胞色素 P450 亚型, 对CYP2C19、CYP2B6、CYP2C9、CYP2C8和CYP3A4的IC50分别为 0.2、0.7、9.7、4.8 和 142.1 μM。 | |||
T13497 | 3'-Hydroxy Repaglinide | Others | Others |
3'-Hydroxy Repaglinide is a main CYP2C8 metabolite of Repaglinide. Repaglinide is a carbamoylmethyl benzoic acid derivative and used as the treatment of type II diabetes. | |||
T11387 |
Gemfibrozil 1-O-β-glucuronide
|
Others | Others |
Gemfibrozil 1-O-β-Glucuronide, a metabolite of Gemfibrozil , is a potent and competitive P450 (CYP) isoform CYP2C8 inhibitor with an IC50 of 4.07 μM. | |||
T67936 |
BAY-0069
|
PPAR | DNA Damage/DNA Repair; Metabolism |
BAY-0069 是一种 PPARγ 反向激活剂,具有有效性和选择性,对人 PPARγ 和鼠 PPARγ 具有抑制作用, IC50 分别为 6.3 nM 和 24 nM。BAY-0069 可用于研究癌症。 | |||
T35635 |
rac-trans-4-hydroxy Glyburide
|
||
rac-trans-4-hydroxy Glyburide is an active metabolite of the SUR1/Kir6.2 sulfonylurea inhibitor glyburide .1,2It is formed from glyburide by the cytochrome P450 (CYP) isoforms CYP2C8 and CYP2C9.1rac-trans-4-hydroxy Glyburide inhibits glyburide binding to rat brain synaptosomes at the high and low affinity sites of SUR1/Kir6.2 with IC50values of 0.95 and 100 nM, respectively.2 1.Zharikova, O.L., Fokina, V.M., Nanovskaya, T.N., et al.Identification of the major human hepatic and placental enzymes ... | |||
T35717 |
N-desmethyl Rosiglitazone
|
||
N-desmethyl Rosiglitazone is a major metabolite of rosiglitazone , a potent and selective PPARγ ligand present in formulations that have been used to treat type 2 diabetes. Rosiglitazone is metabolized by the cytochrome P450 (CYP) isoform CYP2C8 to form N-desmethyl rosiglitazone. | |||
T81744 | mTOR inhibitor-14 | mTOR | PI3K/Akt/mTOR signaling |
mTORinhibitor-14(compound 14c)是一种mTOR高效抑制剂,对CYP2C8的抑制作用较弱,并能有效抑制肿瘤生长。 | |||
T78590 |
Dibenzylfluorescein
DBF |
||
Dibenzylfluorescein(DBF)是一款荧光探针,作为细胞色素P450(CYP)亚型,包括CYP3A4、CYP2C8、CYP2C9、CYP2C19和CYP19的特异性底物,常在Km值0.87-1.9 µM(Ex=485nm,Em=535nm)范围内应用。该探针主要用于监测药物或疾病导致的CYP催化活性变化。 | |||
T14040 |
4-Hydroxytolbutamide
Hydroxytolbutamide |
Potassium Channel | Membrane transporter/Ion channel |
4-Hydroxytolbutamide(Hydroxytolbutamide), a metabolite of Tolbutamide, which is metabolized by CYP2C8 and CYP2C9. Tolbutamide is a first generation potassium channel blocker and a sulfonylurea oral antidiabetic[1][2]. | |||
T36006 |
Olmesartan medoxomil impurity C
|
||
Olmesartan medoxomil impurity C is an Olmesartan medoxomil impurity. Olmesartan medoxomil is a potent and selective angiotensin AT1 receptor inhibitor with IC50 of 66.2 μM. [1]. Senda A, et al. Effects of Angiotensin II Receptor Blockers on Metabolism of Arachidonic Acid via CYP2C8. Biol Pharm Bull. 2015;38(12):1975-9. [2]. Shah S, et al. Simultaneous Quantitative Analysis of Olmesartan Medoxomil and Amlodipine Besylate in Plasma by High-performance Liquid Chromatography Technique. J Young Phar... | |||
T36085 | PKI-179 hydrochloride | ||
PKI-179 is an orally bioavailable dual inhibitor of PI3K and mammalian target of rapamycin (mTOR). In an in vitro enzymatic assay, it potently inhibits PI3K (IC50s = 8, 24, 17, and 74 nM for isoforms α, β, δ, and γ, respectively), two common PI3Kα mutants, E545K and H1047R (IC50s = 14 and 11 nM, respectively), and mTOR (IC50 = 0.42 nM). PKI-179 is selective for PI3K and mTOR over a panel of 361 other kinases at IC50 values up to 50 μM, hERG (IC50 > 30 μM), and cytochrome P450 (CYP) isoforms (IC5... | |||
T7788 |
2-Phenyl-2-(1-piperidinyl)propane
|
Others | Others |
2-Phenyl-2-(1-piperidinyl)propane 是一种具有可逆性、选择性的人 CYP2B6抑制剂,其 IC50为 5.1 μM,Ki 为 5.6。它对 CYP2D6 、CYP3A 均有抑制作用,且 IC50值分别为74 μM、200 μM。 | |||
T36084 |
PKI-179
|
||
PKI-179 is a potent and orally active dual PI3K/mTOR inhibitor, with IC50s of 8 nM, 24 nM, 74 nM, 77 nM, and 0.42 nM for PI3K-α, PI3K-β, PI3K-γ, PI3K-δ and mTOR, respectively. PKI-179 also exhibits activity over E545K and H1047R, with IC50s of 14 nM and 11 nM, respectively. PKI-179 shows anti-tumor activity in vivo[1][2]. PKI-179 inhibits the cell proliferation, with IC50s of 22 nM and 29 nM for MDA361 and PC3 cells, respectively[1].PKI-179 shows inhibitory activity against a panel of 361 other ... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T10835 |
Cletoquine
Desethylhydroxychloroquine |
Parasite; Antifection | Microbiology/Virology |
Cletoquine 是 Hydroxychloroquine 的主要活性代谢物。 Cletoquine 具有对抗基孔肯雅病毒 (CHIKV) 的能力。 Cletoquine 具有抗疟作用,并具有治疗自身免疫性疾病的潜力。 | |||
T3149 |
Salvianolic Acid C
丹酚酸C,丹酚酸 C |
Others; P450 | Metabolism; Others |
Salvianolic acid C 是一种细胞色素 P4502C8(CYP2C8)的非竞争性抑制剂及细胞色素 P4502J2(CYP2J2)中等强度的混合抑制剂,对 CYP2C8 和 CYP2J2 的 Ki 分别为 4.82 μM 和 5.75 μM。 |